1. Hong, Quan, Zhang, Lu, Fu, Jia, He, John C, Lee, Kyung. 2019. LRG1 Promotes Diabetic Kidney Disease Progression by Enhancing TGF-β-Induced Angiogenesis. In Journal of the American Society of Nephrology : JASN, 30, 546-562. doi:10.1681/ASN.2018060599. https://pubmed.ncbi.nlm.nih.gov/30858225/
2. Fu, Zherui, Lai, Yi, Wang, Qianfei, Lin, Feng, Fang, Jiaping. 2023. LRG1 predicts the prognosis and is associated with immune infiltration in thyroid cancer: a bioinformatics study. In Endocrine connections, 13, . doi:10.1530/EC-23-0418. https://pubmed.ncbi.nlm.nih.gov/37991216/
3. Wang, Xuan, Sun, Zeguo, Fu, Jia, He, John C, Lee, Kyung. 2024. LRG1 loss effectively restrains glomerular TGF-β signaling to attenuate diabetic kidney disease. In Molecular therapy : the journal of the American Society of Gene Therapy, 32, 3177-3193. doi:10.1016/j.ymthe.2024.06.027. https://pubmed.ncbi.nlm.nih.gov/38910328/
4. O'Connor, Marie N, Kallenberg, David M, Camilli, Carlotta, Moss, Stephen E, Greenwood, John. 2021. LRG1 destabilizes tumor vessels and restricts immunotherapeutic potency. In Med (New York, N.Y.), 2, 1231-1252.e10. doi:10.1016/j.medj.2021.10.002. https://pubmed.ncbi.nlm.nih.gov/35590198/
5. Chen, Chunyan, Zhang, Jingwei, Yu, Tao, Liao, Jian, Jia, Yifei. 2024. LRG1 Contributes to the Pathogenesis of Multiple Kidney Diseases: A Comprehensive Review. In Kidney diseases (Basel, Switzerland), 10, 237-248. doi:10.1159/000538443. https://pubmed.ncbi.nlm.nih.gov/38799248/
6. Hong, Quan, Wang, Shuqiang, Liu, Shuxin, Chen, Xiangmei, Cai, Guangyan. 2020. LRG1 May Accelerate the Progression of ccRCC via the TGF-β Pathway. In BioMed research international, 2020, 1285068. doi:10.1155/2020/1285068. https://pubmed.ncbi.nlm.nih.gov/32337221/
智鼠故事 
